Indian Medical Device Market - $17.6 Billion by 2020 ? -

There will be a good number of impression seen with the expansion of the medical device space in India, growth of about $10.4 billion to $17.6 billion from the year 2014 to 2020 can be expected to bring a salient Annual Growth Rate(CAGR) of 9.4 percent, by the report of research and consulting firm Global Data. The report says even though the market will not be the same at growth as the pharmaceutical sector, it will be going through significant changes, followed by increasing patient awareness of advanced features in medical technology, and the growing up of population. You could find the Indian Healthcare market in – Indian Healthcare Market Overview.

“India’s medical device market is the rapidly growing market from several other markets, the country’s strong economic growth, improving standards and huge population is the reason for the medical device market growth” says the Global Data’s Senior Industry Analyst Adam Dion. He strong belief is that purchasing power inside the country has risen gradually in the last couple of decades because of high and consistent economic growth and increased job vacancies. Learn More: Indonesia Medical Device Market, Philippines Healthcare market.

Adding to that “the Indian medical devices sector is seeing a profit from the medical tourism market, which attracts the attention by the low cost of the treatments,” he said. With respect to current opportunities within the medical device arena, the huge part is taken up by the ophthalmic devices in market share. In the year 2014, the sales of the devices were evaluated at approximately $3 billion, that have grown at a CAGR of 7.3 % from $1.98 billion in the year 2008.

IBT

Other News

India Medical Device Pricing Strategy: Ensuring Growth & Affordability

| April 27, 2024

India’s National Pharmaceutical Pricing Authority (NPPA) is developing a specialized India medical device pricing strategy for medical devices, transitioning away from the conventional drug-centric framework. This innovative strategy will incorporate international pricing tactics tailored to […]

Imports of High-Value Medical Equipment

| April 20, 2024

High-Value Medical Equipment The Central Drugs Standard Control Organization (CDSCO) and the Central Board of Indirect Taxes & Customs have released a new circular, “F.No.401/40/2021-Cus.III,” detailing updated policies on the import of used high-end medical […]

SEC Committee: Pioneering Medical Approvals

| April 20, 2024

New important article released by Central Drugs Standard Control Organization (CDSCO) titled “SEC – Special Expert Committee, Medical Devices”. Key highlights include the streamlined processes for CDSCO application evaluations, preparation and significance of briefing materials, […]

ErlySign Oral Cancer Detection Technology Gets CDSCO Nod

| April 18, 2024

ErlySign, a Nagpur-based biotech startup, has received approval from the Central Drugs Standard Control Organization (CDSCO) to conduct large-scale clinical trials for its novel oral cancer detection technology. The approval for ErlySign follows a rigorous […]

Additional Steps Announced by FDA to Modernize Clinical Trials

| June 9, 2023

The U.S. Food and Drug Administration has made draft guidance available with updated recommendations for good clinical practices (GCPs), which are intended to modernize the clinical trial design and conduct while maintaining data integrity and […]

Accreditation and Registration Numbers for Foreign Manufacturers Publication by PMDA

| June 8, 2023

This article deals In accordance with the Pharmaceuticals and Medical Devices Act (PMD Act) of Japan, foreign businesses that wish to produce pharmaceuticals, quackery products, active pharmaceutical ingredients (APIs), or medical devices abroad and import […]

BSI New Certification to Mitigate Antimicrobial Resistance Risk in Antibiotic Manufacturing

| June 8, 2023

BSI, the business improvement and standards company, has developed a new certification to mitigate the risk of antimicrobial resistance (AMR) in antibiotic manufacturing. The certification, called the Minimized Risk of Antimicrobial Resistance (AMR) certification, will […]

TUV SUD Inspects IVD Medical Devices’ Cyber Security

| June 6, 2023

The growing digital connectivity of medical infrastructure is resulting in complicated systems with a plethora of diverse interfaces that are potentially vulnerable to assault. The IVD requires producers to provide proof of cyber security before […]

12 3 Next

Post Views: 294

Indian Medical Device Market – $17.6 Billion by 2020 ?